🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
This is a first exploration of GLPG3970 in subjects with active systemic lu...
Status
Terminated
Location
Medical center Medconsult Pleven
Start Date
2020-12-28
Trial ID
NCT04700267
Treatments Being Tested
This is a first-in-human, single-arm, open-label study evaluating the safet...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-11-13
Trial ID
NCT07085104
Treatments Being Tested
Systemic lupus erythematosis (SLE) is a chronic autoimmune disease characte...
Status
Unknown
Location
Multiple Locations
Start Date
2022-02-22
Trial ID
NCT05253638
Treatments Being Tested
Multicentre national cohort study with prospective data collection and biol...
Status
Unknown
Location
Cmg-Ec U1219
Start Date
2021-03-25
Trial ID
NCT04824651
Treatments Being Tested
The purpose of this study is to assess the clinical efficacy, safety, PK, a...
Status
Active Not Recruiting
Location
Investigator Site #1046
Start Date
2023-06-26
Trial ID
NCT05966480
Treatments Being Tested
This is a Phase I-II open- label single-dose study in subjects with signifi...
Status
Terminated
Location
Arkansas Heart Hospital
Start Date
2015-12
Trial ID
NCT02741362
The purpose of this study is to evaluate the long-term safety of anifroluma...
Status
Completed
Location
Research Site
Start Date
2013-03-28
Trial ID
NCT01753193
Treatments Being Tested
This is a Phase I, randomized, placebo-controlled, double-blind, dose-escal...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00541749
Treatments Being Tested